Proteomics targets diabetic kidney disease in Asia
Filed with ASX · · 3 pages · English
Proteomics International Laboratories Ltd. on 6ix
In the deck
Earlier from Proteomics International Laboratories
- Diabetic Kidney Disease Diagnostic Test Data Published
- Appendix 4C - December 2016 Quarterly Report
- Diabetic Kidney Disease patent granted in Russia
- PromarkerD shows improved predictive ability and robustness
- Proteomics completes $1.44 million Placement and offers SPP
Later from Proteomics International Laboratories
- Frost & Sullivan- PromarkerD diagnostic test world leading
- PromarkerD Update
- Appendix 4C - March 2017 Quarterly Report
- World leading laboratory launches clinical trials testing
- Clinical validation study confirms PromarkerD performance
Follow Proteomics International Laboratories into a list and get an email when it puts out news.
Follow Proteomics International Laboratories